Background: Alpha‐fetoprotein (AFP)‐producing gastric cancer (AFPGC) is resistant to chemotherapy and is associated with poor prognosis. Pediatric gastric cancer has an incidence of 0.02% among gastric cancer patients, with a median survival of 5 months.Case: A 13‐year‐old boy presented with progressive dysphagia for 2 months, accompanied by loss of appetite and significant weight loss. Liver dysfunction and multiple lesions were observed. Laboratory investigations revealed elevated liver enzymes and tumor markers, including AFP, at 24 502 ng/mL. Computed tomography (CT) showed thickening of the gastric cardia and multiple liver lesions. Upper gastrointestinal endoscopy revealed a type 2 tumor in the cardia. Histopathology confirmed adenocarcinoma, and immunohistochemical staining was positive for AFP, establishing a diagnosis of AFPGC with liver metastases (Stage IV). Given the unresectable and HER2‐negative nature of the cancer, chemotherapy with TS‐1 and cisplatin was initiated, resulting in a temporary reduction in AFP levels and tumor size. However, disease progression was noted after 3 months, requiring a switch in treatment to ramucirumab, paclitaxel, bleomycin, etoposide, cisplatin, or a study drug. Despite these efforts, the patient succumbed to the disease 16 months after initial treatment.Conclusion: AFPGC in children is extremely rare, with few reported cases. The 16‐month survival observed in this case exceeds previously reported durations (8 and 4 months). Systematic evaluation of persistent gastrointestinal symptoms enabled earlier diagnosis. Standard adult gastric cancer treatment protocols appeared more effective than AFP‐tumor‐specific regimens, suggesting they may be optimal for pediatric AFPGC as well. Early diagnosis through detailed history‐taking and prompt endoscopic examinations in children with gastrointestinal symptoms may lead to significantly prolonged survival and improved management in this rare malignancy.
Introduction: Hepatocellular malignant neoplasm, not otherwise specified (HCN‐NOS) is a newly identified liver tumor with features of mixed hepatoblastoma (HB) and hepatocellular carcinoma (HCC). Although its prognosis and treatment strategies are not well defined, some reports suggested that complete resection with HB‐targeting chemotherapy may yield favorable outcomes. Case Presentation: We present herein a pediatric case of HCN‐NOS in which the tumor was fully resected followed by postoperative chemotherapy. Unfortunately, the patient subsequently died. Conclusion: This case highlights the fact that hepatoblastoma protocols may not always be effective in the treatment of HCN‐NOS; therefore, developing treatment strategies tailored to HCN‐NOS is crucial to improve patient prognosis.
Peritoneal drainage failure is a rare but important complication in pediatric patients, and identifying its underlying cause is crucial for safe and timely management. We report a 7-month-old female infant with trisomy 13 and tetralogy of Fallot who developed respiratory failure secondary to ascites and underwent peritoneal drainage under ultrasound guidance. When drainage subsequently failed, ultrasound revealed a membranous soft-tissue structure—suspected omentum—protruding through a catheter side hole. Conventional maneuvers, including saline flushing and positional changes, were ineffective. Under real-time ultrasound visualization, a guidewire was gently advanced, restoring the membrane to its original position and re-establishing drainage. The catheter was safely removed later the same day without complications. This case illustrates the value of ultrasound for real-time diagnosis and management of catheter obstruction and suggests that a guidewire-based approach may serve as a practical and safe option when standard techniques fail.